[1] Liu B, Han M, Wen JK, et al. Livin/ML?IAP as a new target for cancer treatment[J]. Cancer Lett，2007，250(2):168-176.

[2] 王昊，谭升顺，王新阳，等. siRNA沉默livin基因对恶性黑素瘤LiBr细胞凋亡、周期及增殖的影响[J]. 第四军医大学学报，2007，28(24)：2235-2238.

[3] Wang R, Lin F, Wang X, et al. Silencing Livin gene expression to inhibit proliferation and enhance chemosensitivity in tumor cells[J]. Cancer Gene Ther, 2008,15(6):402-412.

[4] Beurel E, Kornprobst M, Blivet?Van Eqqelpoel MJ, et al. GSK?3 beta inhibition by lithium confers resistance to chemotherapy?induced apoptosis through the repression of CD95(Fas/APO?1) expression[J]. Exp Cell Res, 2004, 300(2):354-364.

[5] Crnkovic MI, Muley T, Meister M, et al. The anti?apoptotic livin gene is an important determinant for the apoptotic resistance of nonsmall cell lung cancer cells[J]. Lung Cancer,2006,54(2):135-142.

[6] Crnkovi? MI, Wagener N, Semzow J, et al. Targeted inhibition of Livin resensitizes renal cancer cells towards apoptosis[J]. Cell Mol Life Sci，2007,64(9):1137-1144.

[7] Izquierdo M. Short interfering RNAs as a tool for cancer gene therapy[J]. Cancer Gene Ther，2005，12(3)：217-227.

[8] 刘平，王同杉，游思洪，等. Livin在人胃癌组织中的表达及其沉默后对胃癌细胞凋亡的影响[J]. 中华肿瘤杂志，2007，29(8)：570-574.

[9] Scott FL, Denault JB, Riedl SJ, et aL. XIAP inhibits caspase?3 And?7 using two binding sites: Evolutionarily conserved mechan?ism of IAPs[J]. EMBO J，2005，24 (3)：645-655.

精品学习网 医药卫生栏目